- Genomics for disease resistance is an important application of modern animal breeding that uses genome-wide genetic information to identify and select animals with improved ability to resist infectious diseases or limit their effects. Disease resistance is a complex trait influenced by many genes, environmental conditions, pathogen characteristics, nutrition, management, and the animal’s immune system. Genomic approaches help breeders understand the genetic basis of disease resistance and improve the accuracy of selection, contributing to healthier livestock populations and more sustainable animal production.
- Disease resistance, disease tolerance, and disease susceptibility are related but distinct concepts. Disease resistance refers to an animal’s ability to prevent infection, restrict pathogen multiplication, or reduce the likelihood of developing disease. Disease tolerance describes the ability to maintain health, production, or biological function despite infection or pathogen exposure. Disease susceptibility refers to an increased likelihood of infection or more severe disease under comparable exposure conditions. Understanding these differences is important because selecting for resistance may reduce pathogen burden, while selecting for tolerance may reduce clinical or production effects without necessarily reducing pathogen transmission.
- The genetic basis of disease resistance can be studied using molecular genetic markers, single-nucleotide polymorphisms (SNPs), candidate genes, and genome-wide approaches. Genes involved in immune recognition, antigen presentation, inflammatory responses, and pathogen defense may contribute to differences in disease outcomes. For example, variation in genes within the major histocompatibility complex (MHC) can influence immune recognition in many animal species. However, disease resistance is rarely determined by a single gene, and the effects of specific variants can differ among breeds, pathogens, and environmental conditions.
- Genome-wide association studies (GWAS) help identify genomic regions associated with disease-related traits by examining relationships between genetic variants and recorded disease outcomes. These regions may contain or be linked to genes that influence immune function, susceptibility, or disease severity. Quantitative trait loci (QTL) analysis and candidate gene studies can provide additional information about the genetic architecture of resistance. However, an association does not automatically establish that a variant causes resistance; further validation is needed before applying findings in breeding programs.
- Genomic selection is particularly useful when disease resistance is influenced by many genetic variants, each with a relatively small effect. By combining genome-wide marker data with reliable health records, diagnostic test results, and other relevant phenotypes, breeders can estimate genomic breeding values for disease-related traits. These predictions help identify breeding animals with favorable genetic potential, including young animals that have not yet been exposed to a disease or have insufficient individual health records. The accuracy of genomic prediction depends on the size and representativeness of the reference population, the quality of disease phenotypes, trait heritability, genetic relationships, and the similarity between the reference and target populations.
- Reliable phenotyping is essential for successful genomic improvement of disease resistance. Records may include confirmed diagnoses, pathogen detection, clinical signs, disease incidence, severity, mortality, treatment requirements, immune responses, or validated indicators of infection. Differences in exposure, vaccination, treatment, housing, nutrition, and management must be considered because animals that appear disease-free may simply have experienced less exposure. Standardized health recording and appropriate statistical models help separate genetic differences from environmental effects and reduce bias in genetic evaluation.
- Genomics for disease resistance has applications in dairy cattle, beef cattle, pigs, poultry, sheep, goats, and aquaculture species. Breeding objectives may include resistance to mastitis, respiratory diseases, parasitic infections, enteric diseases, and other economically or biologically important conditions. The relevant traits and genetic mechanisms vary among species and pathogens, so genetic findings should be validated in the populations and production systems where they will be used. Genetic resistance can complement vaccination, biosecurity, veterinary care, nutrition, and improved husbandry, but it does not replace these disease-control measures.
- Several challenges must be addressed when selecting for disease resistance. Some disease traits have low heritability, are difficult or expensive to measure, or require controlled challenge studies that raise animal-welfare concerns. Pathogens may evolve, and resistance to one disease may not provide protection against another. Genetic correlations between disease resistance, production, fertility, and other traits may also create trade-offs. Breeding programs should therefore use balanced selection indexes, monitor genetic diversity and inbreeding, and avoid excessive selection on a narrow set of immune-related variants that could have unintended consequences.
- Genomics can also support the study of host–pathogen interactions, immune function, genotype–environment interaction, and the genetic mechanisms underlying variation in disease outcomes. As genomic technologies and health-data systems improve, integrating genomic information with veterinary records, pathogen surveillance, and environmental data can strengthen disease-resistance prediction and breeding decisions. Nevertheless, genetic resistance is only one component of livestock health, and its effectiveness depends on the disease, population, and production environment.
- Overall, genomics for disease resistance provides a valuable foundation for breeding livestock with improved health, resilience, and long-term productivity. By combining genome-wide data, accurate disease phenotypes, reliable genetic evaluation, and balanced breeding objectives, animal breeders can make more informed selection decisions while supporting animal welfare, reduced disease burden, and sustainable livestock production.
